BioMarin Pharmaceutical Inc. (BMRN) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BioMarin Pharmaceutical I...

    NASDAQ: BMRN · Real-Time Price · USD
    53.85
    1.23 (2.34%)
    At close: Sep 26, 2025, 3:59 PM
    54.00
    0.28%
    After-hours: Sep 26, 2025, 07:56 PM EDT

    BioMarin Pharmaceutical Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 426.86M 167.65M 141.56M -64.08M
    Depreciation & Amortization
    		 96.43M 104.39M 101.97M 108.04M
    Stock-Based Compensation
    		 201.57M 207.1M 196.31M 197.26M
    Other Working Capital
    		 -62.72M -57.9M -5.1M 19.83M
    Other Non-Cash Items
    		 8.29M 61.65M -115.47M 12.89M
    Deferred Income Tax
    		 56.1M -44.98M -52.09M -15.61M
    Change in Working Capital
    		 -216.4M -336.54M -96.38M 66.03M
    Operating Cash Flow
    		 572.84M 159.26M 175.9M 304.54M
    Capital Expenditures
    		 -97.42M -107.61M -131.54M -119.22M
    Cash Acquisitions
    		 n/a n/a n/a -23.65M
    Purchase of Investments
    		 -410.25M -868.5M -611.81M -937.14M
    Sales Maturities Of Investments
    		 633.02M 864.86M 620M 691.05M
    Other Investing Acitivies
    		 -853K -10.92M 103.33M 22.65M
    Investing Cash Flow
    		 136.49M -111.24M -20.03M -366.31M
    Debt Repayment
    		 -494.99M -2.29M -2.6M -3.04M
    Common Stock Repurchased
    		 n/a -76.32M -54.28M -45.8M
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -80.74M -85.79M -85.38M -46.2M
    Financial Cash Flow
    		 -526.45M -18.73M -18.65M -48K
    Net Cash Flow
    		 187.72M 30.6M 137.25M -61.88M
    Free Cash Flow
    		 475.42M 51.65M 44.36M 185.31M

    Add to Watchlist